Combo against T315I mutation

[Guest guest]

For those of you who subscribe to the Asian CML list

(http://asia./group/AsianCMLSupportGroup/) Roy has just

written a nice summary (post #31610) of an in-vitro study of a combination

of IM plus a new phosphoinositide-dependent kinase-1 inhibitor OSU-03012,

showing efficacy against the T315I mutation, which I just referrred to in a

previous post. I gather from Roy's post that they're working to accelerate

the approval process for a clinical trial - first of OSU-03012, then of the

combination.

Thanks Roy - if you're listening.

R